Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Dec;78(12):1573–1577. doi: 10.1038/bjc.1998.725

Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue.

H Saito 1, S Tsujitani 1, M Ikeguchi 1, M Maeta 1, N Kaibara 1
PMCID: PMC2063230  PMID: 9862566

Abstract

It has been reported that decreased numbers of dendritic cells (DCs) are correlated with poor prognosis in some types of malignancy, such as gastric cancer. However, factors that determine the density of DCs have not been characterized. It was recently reported that vascular endothelial growth factor (VEGF) inhibits the functional maturation of DCs from CD34+ precursors. In this study, we analysed the relationship between the expression of VEGF and the density of DCs in gastric carcinoma tissues by immunohistochemical staining. The extent of infiltration by DCs was graded from marked to slight on the basis of the mean densities of DCs. The prognosis of patients with marked infiltration was significantly better than that of patients with slight infiltration among patients who had undergone curative resection. Multivariate analysis showed that infiltration by DCs was an independent prognostic indicator. Furthermore, there was an inverse correlation between the density of DCs and the expression of VEGF Our results suggest that expression of VEGF might be associated with tumour progression and poor prognosis not only because VEGF stimulates angiogenesis, but also because it allows tumours to escape from attack by the immune system in patients with gastric carcinoma.

Full text

PDF
1573

Images in this article

1574Figure 1
on p.1574
1574Figure 2
on p.1574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fontanini G., Vignati S., Boldrini L., Chinè S., Silvestri V., Lucchi M., Mussi A., Angeletti C. A., Bevilacqua G. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res. 1997 Jun;3(6):861–865. [PubMed] [Google Scholar]
  2. Gabrilovich D. I., Nadaf S., Corak J., Berzofsky J. A., Carbone D. P. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol. 1996 May 25;170(1):111–119. doi: 10.1006/cimm.1996.0140. [DOI] [PubMed] [Google Scholar]
  3. Inoue K., Ozeki Y., Suganuma T., Sugiura Y., Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer. 1997 Jan 15;79(2):206–213. doi: 10.1002/(sici)1097-0142(19970115)79:2<206::aid-cncr2>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  4. Kakeji Y., Maehara Y., Korenaga D., Tsujitani S., Haraguchi M., Watanabe A., Orita H., Sugimachi K. Prognostic significance of tumor-host interaction in clinical gastric cancer: relationship between DNA ploidy and dendritic cell infiltration. J Surg Oncol. 1993 Apr;52(4):207–212. doi: 10.1002/jso.2930520402. [DOI] [PubMed] [Google Scholar]
  5. Katoh O., Tauchi H., Kawaishi K., Kimura A., Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 1995 Dec 1;55(23):5687–5692. [PubMed] [Google Scholar]
  6. Maeda K., Chung Y. S., Ogawa Y., Takatsuka S., Kang S. M., Ogawa M., Sawada T., Sowa M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer. 1996 Mar 1;77(5):858–863. doi: 10.1002/(sici)1097-0142(19960301)77:5<858::aid-cncr8>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  7. Maehara Y., Tomisaki S., Oda S., Kakeji Y., Tsujitani S., Ichiyoshi Y., Akazawa K., Sugimachi K. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. Int J Cancer. 1997 Apr 22;74(2):224–228. doi: 10.1002/(sici)1097-0215(19970422)74:2<224::aid-ijc15>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  8. Miyake M., Taki T., Hitomi S., Hakomori S. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med. 1992 Jul 2;327(1):14–18. doi: 10.1056/NEJM199207023270103. [DOI] [PubMed] [Google Scholar]
  9. Nakano T., Oka K., Arai T., Morita S., Tsunemoto H. Prognostic significance of Langerhans' cell infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med. 1989 May;113(5):507–511. [PubMed] [Google Scholar]
  10. Nomori H., Watanabe S., Nakajima T., Shimosato Y., Kameya T. Histiocytes in nasopharyngeal carcinoma in relation to prognosis. Cancer. 1986 Jan 1;57(1):100–105. doi: 10.1002/1097-0142(19860101)57:1<100::aid-cncr2820570121>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  11. O'Reilly M. S., Holmgren L., Shing Y., Chen C., Rosenthal R. A., Moses M., Lane W. S., Cao Y., Sage E. H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994 Oct 21;79(2):315–328. doi: 10.1016/0092-8674(94)90200-3. [DOI] [PubMed] [Google Scholar]
  12. Tsujitani S., Furukawa T., Tamada R., Okamura T., Yasumoto K., Sugimachi K. Langerhans cells and prognosis in patients with gastric carcinoma. Cancer. 1987 Feb 1;59(3):501–505. doi: 10.1002/1097-0142(19870201)59:3<501::aid-cncr2820590325>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  13. Tsujitani S., Kakeji Y., Watanabe A., Kohnoe S., Maehara Y., Sugimachi K. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer. 1990 Nov 1;66(9):2012–2016. doi: 10.1002/1097-0142(19901101)66:9<2012::aid-cncr2820660928>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  14. Yamaoka M., Yamamoto T., Masaki T., Ikeyama S., Sudo K., Fujita T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res. 1993 Sep 15;53(18):4262–4267. [PubMed] [Google Scholar]
  15. Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 1993 Jun 1;53(11):2566–2570. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES